04:31 AM EDT, 03/20/2026 (MT Newswires) -- Jeffrey S Farrow, Chief Financial Officer and Chief Strategy Officer, on March 17, 2026, sold 6,430 shares in Tarsus Pharmaceuticals ( TARS ) for $439,566. Following the Form 4 filing with the SEC, Farrow has control over a total of 43,316 common shares of the company, with 43,316 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1819790/000140525326000007/xslF345X05/wk-form4_1773961430.xml